SULLIVAN BENJAMIN,SULLIVAN Benjamin,SCHMIDT TANNIN A.,SCHMIDT Tannin A.,SULLIVAN DAVID A.,SULLIVAN David A.
申请号：
SI200931129
公开号：
SI2285364T1
申请日:
2009.04.08
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The present invention provides a pharmaceutical composition, and methods of use thereof, for treating ocular boundary deficiency, symptoms associated therewith, or undesired condition that is associated with or causes ocular boundary deficiency at the ocular surface. The pharmaceutical composition of the present invention comprises a human PRG4 protein, a lubricant fragment, homolog, or isoform thereof, suspended in an ophthalmically acceptable balanced salt solution. The pharmaceutical composition of the present invention may also comprise one or more ophthalmically acceptable agents selected from the group consisting of an ophthalmically acceptable demulcent. excipient, astringent, vasoconstrictor, emollient, sodium hyaluronate, hyaluronic acid, and surface active phospholipids, in a pharmaceutically acceptable carrier for topical administration.
